Stonepine Capital Management, LLC, 10% Owner at Recro Pharma, Inc. (REPH), sold 480,454 shares at $7.64 ($3.7M) on 2017-05-09, disclosed to the SEC on 2017-05-11.
Open-market sale of $3.7M REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.64 | 33,070 | $253K | 6.9% |
| 2 | $7.64 | 33,070 | $253K | 6.9% |
| 3 | $7.64 | 195,059 | $1.5M | 40.5% |
| 4 | $7.64 | 195,059 | $1.5M | 40.5% |
| 5 | $7.77 | 1,088 | $8K | 0.2% |
| 6 | $7.77 | 6,412 |
| $50K |
| 1.4% |
| 7 | $7.96 | 1,304 | $10K | 0.3% |
| 8 | $7.96 | 7,696 | $61K | 1.7% |
| 9 | $7.96 | 7,696 | $61K | 1.7% |
| Total | $7.65 avg | 480,454 | $3.7M | 100% |
| Filing → |